Masitinib CAS 790299-79-5
Masitinib is a tyrosine kinase inhibitor. Its clinical indications include amyotrophic lateral sclerosis, mastocytosis, pancreatic cancer, multiple sclerosis, asthma, prostate cancer, etc.
Item | Specification |
MW | 498.64 |
Density | 1.280±0.06 g/cm3(Predicted) |
EINECS | 226-164-5 |
pKa | 13.24±0.70(Predicted) |
Melting point | 90-95°C |
Storage conditions | Refrigerator |
Masitinib, Also known as mesatinib mesylate, it is a platelet-derived growth factor alpha/beta receptor tyrosine kinase inhibitor developed by AB Science for the treatment of multiple myeloma, gastrointestinal stromal tumors, and prostate cancer.
Usually packed in 25kg/drum,and also can be do customized package.
Masitinib CAS 790299-79-5
Masitinib CAS 790299-79-5
Write your message here and send it to us